US2021161570A1PendingUtilityA1

Composition, method and device for stabilizing implanted hydraulic devices

Assignee: FORSELL PETERPriority: Oct 10, 2008Filed: Feb 16, 2021Published: Jun 3, 2021
Est. expiryOct 10, 2028(~2.2 yrs left)· nominal 20-yr term from priority
Inventors:Peter Forsell
A61F 5/0056B29C 73/025A61B 17/7097B29C 73/02A61B 17/8802A61B 17/8841A61F 5/0059A61B 17/7095A61B 17/7094
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a kit for stabilizing an implanted device. The kit komprises a composition for stabilizing an implanted device, and a syringe for introducing the composition into an implanted device. The composition is a composition comprising a solidifying fluid, an initiator adapted to exert influence on a solidifying fluid, and a mixture of a solidifying fluid and an initiator.

Claims

exact text as granted — not AI-modified
1 .- 46 . (canceled) 
     
     
         47 . A kit for stabilizing an implanted device comprising
 a composition for stabilizing an implanted device, wherein said composition is a composition comprising a solidifying fluid, an initiator adapted to exert influence on a solidifying fluid, and a mixture of a solidifying fluid and an initiator, and   a syringe for introducing the composition into an implanted device.   
     
     
         48 . The kit according to  claim 47 , wherein the syringe includes a first compartment for a first component of the sterile composition, and a second compartment for a second component of the sterile composition, and a mixing chamber into which the first component and the second component can be introduced and mixed, before introduction into the implanted device. 
     
     
         49 . The kit according to  claim 47 , wherein the kit further comprising a temperature controller for adjusting the temperature of at least one of the components to a predetermined value, and/or for maintaining the temperature of at least one of the components at a predetermined value, when the at least one component is positioned in the syringe. 
     
     
         50 . The kit according to  claim 47 , wherein the syringe comprises a needle adapted to be introduced into an injection port arranged in fluid connection with the implanted device. 
     
     
         51 . The kit according to  claim 47 , wherein said solidifying fluid comprises a curable component, and the initiator added to said fluid is chosen from a polymerization initiator, a cross-linking agent, and a catalyst. 
     
     
         52 . The kit according to  claim 47 , wherein said initiator is at least one chosen from air, nitrogen, and oxygen. 
     
     
         53 . The kit according to  claim 49 , wherein said solidifying fluid comprises a curable component adapted to solidify when exposed to a change in temperature. 
     
     
         54 . The kit according to  claim 47 , wherein the composition is a sterile component comprising a monomer or polymer and a solvent. 
     
     
         55 . The kit according to  claim 54 , wherein the composition the sterile component further comprises a propellant. 
     
     
         56 . The kit according to  claim 54 , wherein said polymer is a thixotropic gel. 
     
     
         57 . The kit according to  claim 56 , wherein said polymer is chosen among polyhydroxy acid polymers and copolymers such as poly-L-lactide, poly-DL-lactide, polyglycolide, and polydioxanone 
     
     
         58 . The kit according to  claim 54 , wherein said polymer further comprises reinforcing particles. 
     
     
         59 . The kit according to  claim 58 , wherein said reinforcing particles are chosen among biocompatible ceramic particles and fibres made up of calcium phosphates. 
     
     
         60 . The kit according to  claim 54 , wherein said composition further comprises a polymerization initiator. 
     
     
         61 . The kit according to  claim 47 , wherein the composition comprising two miscible components, wherein a first component is present in a hydraulic fluid suitable for use in an implanted hydraulic device, and a second component which is added to said fluid, wherein the two components when brought in contact with each other form a stable composition. 
     
     
         62 . The kit according to  claim 61 , wherein said first composition is sterile. 
     
     
         63 . The kit according to  claim 61 , wherein said second composition is sterile. 
     
     
         64 . The kit according to  claim 61 , wherein said first and second component are biocompatible. 
     
     
         65 . The kit according to  claim 61 , wherein said first component comprises polyurethane, and said second component is a gas. 
     
     
         66 . The kit according to  claim 65 , wherein said gas is chosen from air, nitrogen, and oxygen.

Join the waitlist — get patent alerts

Track US2021161570A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.